Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. - Wikidata - wikimedia - TriplyDB

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

http://www.wikidata.org/entity/Q39338191

about

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement The molecular pathogenesis of pituitary adenomas: an update Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis X-linked acrogigantism syndrome: clinical profile and therapeutic responses ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.The genetic background of acromegaly.Familial isolated pituitary adenomas: an emerging clinical entity.Aggressive tumors and difficult choices in acromegaly.The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.Genetic mutations in sporadic pituitary adenomas--what to screen for?Treatment of acromegaly in the era of personalized and predictive medicine.Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.Genetics of gigantism and acromegaly.AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.Somatostatin receptor ligands in the treatment of acromegaly.Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression.Familial pituitary adenomas - who should be tested for AIP mutations?A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland.In vivo bioassay to test the pathogenicity of missense human AIP variants.Somatotroph-Specific Aip-Deficient Mice Display Pretumorigenic Alterations in Cell-Cycle Signaling.Genetics of Cushing's Syndrome.Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

P2860

Q26770701-60767F51-D0BE-418D-80FE-E0DACAC46190 Q26830047-160F9892-2C70-4835-8EF7-23F9FCE61ED8 Q27675839-2E7ADA39-7C89-44EB-8B15-0C732E2FE197 Q27693237-77D15B6F-0CC4-463F-9E68-66B5907FCED8 Q30370618-8892AD22-E744-4E1F-8846-BC6E568008DD Q35009758-B183C521-3A10-47A1-97ED-8D41E0E25707 Q35057730-67697B10-DF7B-4828-89C9-B614A4DA3C0D Q36153987-46175D25-306F-4957-A34A-83AB649E58CA Q36270932-DDE90AFC-E20D-4745-91B1-909E57712B68 Q36724063-24B35606-51EB-4CAC-8D18-96D73249F29C Q37678059-D0434291-107F-46FB-8A13-54DA0717F953 Q38073256-B85712BB-D2FD-4DDF-9B01-7D51E4598F8A Q38167711-F36F3537-51D6-492E-80AA-B5B1714C7CD6 Q38173701-72BB6A44-1C6B-4F0C-A860-755B5FEFE790 Q38263242-FF7ED0FF-F05E-454D-A2E9-F9B2C2A82580 Q38340014-2B4C99A3-45F4-40C0-8F2E-41DE0C3C79E5 Q38944306-C9B1055F-825E-4F55-B093-E47B1686A013 Q38961684-D9278494-BAA7-4774-90EB-14AB21E854ED Q39012320-71971C32-30A8-4919-A476-FCBABC0E9F6F Q39125449-47567DEB-75AE-4774-8295-8BED5015C86F Q44117894-7CF7C655-DAE2-4233-96ED-F204DE7A9A8B Q47735880-9F360CEB-1023-47EA-A610-FA13647712C4 Q52651698-F2D1E723-438B-44C9-9BDB-603E56B311D6 Q52672961-3EEF7A65-D0B2-4E5B-A1BC-EFB47C7576E1 Q52720533-8C1A7169-8709-4AC6-9B3C-40294C011088 Q52738997-185603C3-9F44-406B-84B7-B662A42A389B Q53683262-A89630AE-9553-4141-957D-7C1FBC542B17 Q54979751-0879E21D-5436-43C7-B369-33A58CF54DAA Q57144951-A30AA8A0-9512-42D2-8C1F-EBAC39C57397

P2860

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

http://www.wikidata.org/entity/Q39338191

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

@en

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

@nl

type

label

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

@en

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

@nl

prefLabel

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

@en

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

@nl

P1433

Q39338191-C8613618-44F1-4D3B-9E19-A1C06EC1A257

P1476

Q39338191-4B093958-9AA0-4BCD-86F9-DC79879206A4

P2093

Q39338191-15B1944E-9353-40B4-BFD7-58783389C79A

Q39338191-1B9FCA25-E1D6-4AFA-8135-07751BC25CFF

Q39338191-253CFB8B-F649-4F56-958C-754898814451

Q39338191-33279220-885F-4D53-9035-BE9A70CD2721

Q39338191-3D5388BD-B7E0-40DB-A622-D05386076726

Q39338191-4F88E69C-CC74-4193-BDB5-425EEF58E19E

Q39338191-66ADACA3-CCBA-4A17-B110-6C024AAEDB46

Q39338191-71F19430-C495-493C-B785-E3C20558C236

Q39338191-830B17FB-7E08-4105-8B9D-EA49E3230065

Q39338191-9498C4FD-2F6F-49F9-B1B4-AA3E5390C3E3

P304

Q39338191-FDE2A571-1CFD-4FE9-9F14-AED9D78DD638

P31

Q39338191-AAFDA7AF-E5A0-4EF2-B197-59083CE2E66A

P356

Q39338191-CF05092C-20E3-40C9-8222-02595B29B978

P407

Q39338191-C8DB0BC4-E556-46B9-AA66-9410AE2180D6

P433

Q39338191-BEB335FD-0865-43AB-B8AA-AD6509D67651

P478

Q39338191-3E76E93C-7492-45A1-83C9-14C38D983596

P50

Q39338191-28C105DD-3439-40D8-84D8-DB9C3F110BCB

Q39338191-3F2C0D3E-C8FD-4D0A-8D85-963885516C60

Q39338191-44FB15C0-C6DB-4E62-BF80-CC86175DE923

Q39338191-83878630-286C-4461-8D81-C6408ECBD432

Q39338191-BE7E0C26-0829-4E2E-928E-36B5378F3896

Q39338191-DF6A48CB-1D5C-484E-8056-D7755DE8640E

Q39338191-E0F0A43E-D91D-46FE-9FFC-65F276AF00F9

P577

Q39338191-EEFB6FB1-90CE-4BBE-989C-601B64171CBC

P5875

Q39338191-4F0F6BA9-CE95-4A69-8619-AC5DB2083F3B

P698

Q39338191-111CFF96-F03A-4A38-BA69-C9F3E0A098ED

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway

@en

P2093

Amelie Lupp

http://www.w3.org/2001/XMLSchema#string

Ashley B Grossman

http://www.w3.org/2001/XMLSchema#string

Asil Tahir

http://www.w3.org/2001/XMLSchema#string

Chrysanthia A Leontiou

http://www.w3.org/2001/XMLSchema#string

Eivind Carlsen

http://www.w3.org/2001/XMLSchema#string

Harvinder S Chahal

http://www.w3.org/2001/XMLSchema#string

John A H Wass

http://www.w3.org/2001/XMLSchema#string

Neda Alband

http://www.w3.org/2001/XMLSchema#string

Olaf Ansorge

http://www.w3.org/2001/XMLSchema#string

Susan Jordan

http://www.w3.org/2001/XMLSchema#string

P304

E1411-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2012-1111

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Giampaolo Trivellin

Marta Korbonits

Niki Karavitaki

Susana C Igreja

Robert C Fowkes

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225094740

http://www.w3.org/2001/XMLSchema#string

P698

22659247

http://www.w3.org/2001/XMLSchema#string